FTH
Faeth Therapeutics, Inc.- Healthcare
- Biotechnology
- $568M market cap
Forecast run · Nov 10, 2026Upside rank 141 of 3,179
Model Signal
ForecastQ Daily Probabilities
68.9%
27.2%
73.1%
Analyst Consensus
Recommendation2.00/5 Buy
Last price$22.05
Price target$58.50
Implied move+165.3%
Analysts6
ForecastQ Portfolios
Company Profile
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]